Balsalazide
Total Payments
$397,842
Transactions
1
Doctors
0
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2017 | $397,842 | 1 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $397,842 | 1 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Balsalazide Fed Pivotal Study | West-Ward Pharmaceuticals | $397,842 | 0 |
Top Doctors Receiving Payments for Balsalazide
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Austin, TX | $397,842 | 1 |
Ad
Manufacturing Companies
- West-Ward Pharmaceuticals $397,842
Product Information
- Type Drug
- Total Payments $397,842
- Total Doctors 0
- Transactions 1
About Balsalazide
Balsalazide is a drug associated with $397,842 in payments to 0 healthcare providers, recorded across 1 transactions in the CMS Open Payments database. The primary manufacturer is West-Ward Pharmaceuticals.
Payment data is available from 2017 to 2017. In 2017, $397,842 was paid across 1 transactions to 0 doctors.
The most common payment nature for Balsalazide is "Unspecified" ($397,842, 100.0% of total).
Balsalazide is associated with 1 research study, including "Balsalazide Fed Pivotal Study" ($397,842).